| FOXA1, GATA3 and PPARɣ cooperate to drive luminal subtype in bladder cancer: a molecular analysis of established human cell lines JI Warrick, V Walter, H Yamashita, E Chung, L Shuman, VO Amponsa, ... Scientific reports 6 (1), 38531, 2016 | 143 | 2016 |
| On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer H Yamashita, VO Amponsa, JI Warrick, Z Zheng, PE Clark, JD Raman, ... Nature Reviews Urology 14 (2), 98-106, 2017 | 40 | 2017 |
| Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer V Osei-Amponsa, JM Buckwalter, L Shuman, Z Zheng, H Yamashita, ... Oncogene 39 (6), 1302-1317, 2020 | 33 | 2020 |
| FOXA1, GATA3 and PPAR [Latin small letter gamma] cooperate to drive luminal subtype in bladder cancer: a molecular analysis of established human cell lines JI Warrick, V Walter, H Yamashita, E Chung, L Shuman, VO Amponsa, ... Sci Rep 6 (1), 38531, 2016 | 27 | 2016 |
| Proteasome substrate receptors and their therapeutic potential V Osei-Amponsa, KJ Walters Trends in biochemical sciences 47 (11), 950-964, 2022 | 25 | 2022 |
| Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma X Lu, VR Sabbasani, V Osei-Amponsa, CN Evans, JC King, SG Tarasov, ... Nature Communications 12 (1), 7318, 2021 | 19 | 2021 |
| Impact of losing hRpn13 Pru or UCHL5 on proteasome clearance of ubiquitinated proteins and RA190 cytotoxicity V Osei-Amponsa, V Sridharan, M Tandon, CN Evans, K Klarmann, ... Molecular and Cellular Biology 40 (18), e00122-20, 2020 | 19 | 2020 |
| Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274/Pdl-1 expression VO Amponsa, L Shuman, J Ellis, E Wang, V Walter, RG Owens, M Zaleski, ... American Journal of Clinical and Experimental Urology 7 (3), 139, 2019 | 7 | 2019 |
| hRpn13 shapes the proteome and transcriptome through epigenetic factors HDAC8, PADI4, and transcription factor NF-κB p50 V Osei-Amponsa, M Chandravanshi, X Lu, V Magidson, S Das, ... Molecular Cell 84 (3), 522-537. e8, 2024 | 2 | 2024 |
| An engineered cell line with a hRpn1-attached handle to isolate proteasomes H Negi, V Osei-Amponsa, B Ibrahim, CN Evans, C Sullenberger, ... Journal of Biological Chemistry 299 (8), 2023 | 2 | 2023 |
| MP51-12 INACTIVATION OF FOXA1 COOPERATES WITH PTEN COPY NUMBER LOSS IN BLADDER CANCER TO PROMOTE TUMOR HETEROGENEITY L Shuman*, V Osei-Amponsa, J Buckwalter, Z Zheng, H Yamashita, ... The Journal of Urology 201 (Supplement 4), e727-e728, 2019 | | 2019 |
| MP51-11 EPIGENETIC REGULATION OF FORKHEAD BOX A1 IN ADVANCED BLADDER CANCER J Buckwalter*, VO Amponsa, L Shuman, V Walter, J Warrick, XR Wu, ... The Journal of Urology 201 (Supplement 4), e727-e727, 2019 | | 2019 |
| Alterations in FOXA1 and PTEN Expression Contribute to Morphologic and Molecular Heterogeneity in Bladder Cancer VO Amponsa The Pennsylvania State University, 2019 | | 2019 |
| MP54-01 TRANSCRIPTION FACTOR ACTIVATOR PROTEIN 2 FAMILY MEMBERS ARE MARKERS OF THE BASAL MOLECULAR SUBTYPE OF HUMAN BLADDER CANCER AND REPRESSED BY LUMINAL TRANSCRIPTIONAL … L Shuman, H Yamashita, Z Zheng, T Tran, V Osei-Amponsa, J Warrick, ... The Journal of Urology 199 (4S), e712-e712, 2018 | | 2018 |
| Novel transgenic knockout model of basal-squamous bladder cancer. V Osei Amponsa, Z Zheng, V Walter, J Warrick, C Mendelsohn, ... Journal of Clinical Oncology 36 (6_suppl), 459-459, 2018 | | 2018 |
| MP65-16 INACTIVATION OF FOXA1 AND PTEN RESULTS IN DEVELOPMENT OF CARCINOMA IN SITU AND THE BASAL SUBTYPE OF MUSCLE INVASIVE BLADDER CANCER FOLLOWING CARCINOGEN EXPOSURE V Osei-Amponsa, Z Zheng, S Bouza, J Warrick, C Mendelsohn, ... The Journal of Urology 197 (4S), e859-e860, 2017 | | 2017 |
| PD38-03 CHARACTERIZATION OF CELL BASED MODELS FOR THE IN VITRO AND IN VIVO STUDY OF DISCRETE MOLECULAR SUBTYPES IN BLADDER CANCER W Chan, J Warrick, L Shuman, Z Zheng, H Yamashita, V Osei Amponsa, ... The Journal of Urology 195 (4S), e924-e924, 2016 | | 2016 |
| Molecular Subtyping and In Vivo Phenotyping Studies Identify Human Cell Lines Suitable for Bladder Cancer Research J Warrick, L Shuman, Z Zheng, H Yamashita, VO Amponsa, D DeGraff The FASEB Journal 30, 445.3-445.3, 2016 | | 2016 |
| MP83-03 EXPRESSION OF TRANSCRIPTION FACTOR AP2 (TFAP2) FAMILY MEMBERS ARE ASSOCIATED WITH THE BASAL MOLECULAR SUBTYPE OF HUMAN BLADDER CANCER AND ALTERED NOTCH PATHWAY ACTIVITY W Chan, T Tran, H Yamashita, Z Zheng, V Osei Amponsa, Y Imamura, ... The Journal of Urology 195 (4S), e1081-e1082, 2016 | | 2016 |
| MP68-10 EXPRESSION OF TFAP2C IS ASSOCIATED WITH THE BASAL MOLECULAR SUBTYPE OF BLADDER CANCER AND INCREASED TUMOR AGGRESSIVENESS H Yamashita, Z Zheng, V Osei Amponsa, J Raman, D DeGraff The Journal of Urology 193 (4S), e861-e861, 2015 | | 2015 |
